Positron emission tomography ligand [11C]5-hydroxy- Tryptophan can be used as a surrogate marker for the human endocrine pancreas

Diabetes

Volumn 63, Issue 10, 2014, Pages 3428-3437

  Eriksson, Olof ^a   Espes, Daniel ^a   Selvaraju, Ram K ^a   Jansson, Emma ^a   Antoni, Gunnar ^a   Sorensen, Jens ^a   Lubberink, Mark ^a   Biglarnia, Ali Reza ^a   Eriksson, Jan W ^a,b   Sundin, Anders ^a   Ahlström, Håkan ^a   Eriksson, Barbro ^a   Johansson, Lars ^a,b   Carlsson, Per Ola ^a   Korsgren, Olle ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b ASTRAZENECA R AND D   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYTRYPTOPHAN C 15; C PEPTIDE; INSULIN; SEROTONIN; TRACER; UNCLASSIFIED DRUG; 5 HYDROXYTRYPTOPHAN; CARBON;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CELL STRUCTURE; CELL VOLUME; CLINICAL ARTICLE; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC PATIENT; DISEASE MARKER; DRUG ACCUMULATION; DRUG RETENTION; DRUG UPTAKE; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MIDDLE AGED; PANCREAS ISLET; PANCREAS ISLET BETA CELL; POSITRON EMISSION TOMOGRAPHY; SEROTONINERGIC SYSTEM; YOUNG ADULT; ADOLESCENT; CLINICAL TRIAL; DRUG EFFECT; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SCINTISCANNING;

5-HYDROXYTRYPTOPHAN; ADOLESCENT; ADULT; AGED; CARBON RADIOISOTOPES; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; ISLETS OF LANGERHANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84907495074     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db13-1877     Document Type: Article

References (38)

1. Normandin MD, Petersen KF, Ding YS, et al. In vivo imaging of endogenous pancreatic ß-cell mass in healthy and type 1 diabetic subjects using 18F-fluoropropyl-dihydrotetra ben az i ne and PET. J Nucl Med 2012;53:908-916
2. 11C-dihydrotetrabenazine PET of the pancreas in subjects with long-standing type 1 diabetes and in healthy controls. J Nucl Med 2009;50:382-389
3. Andralojc K, Srinivas M, Brom M, et al. Obstacles on the way to the clinical visualisation of beta cells: Looking for the Aeneas of molecular imaging to navigate between Scylla and Charybdis. Diabetologia 2012;55:1247-1257
4. 68Ca-labeled D03A-exendin-4. J Nucl Med 2013;54:1458-1463
5. 111In-labelled exendin. Diabetologia 2014;57:950-959
6. Wilson ME, Scheel D, German MS. Gene expression cascades in pancreatic development. Mech Dev 2003;120:65-80
7. Cordes SP. Molecular genetics of the early development of hindbrain serotonergic neurons. Clin Genet 2005;68:487-494
8. Ohta Y, Kosaka Y, Kishimoto N, et al. Convergence of the insulin and serotonin programs in the pancreatic ß-cell. Diabetes 2011;60:3208-3216
9. Ekholm R, Ericson LE, Lundquist I. Monoamines in the pancreatic islets of the mouse. Subcellular localization of 5-hydroxytryptamine by electron microscopic autoradiography. Diabetologia 1971;7:339-348
10. Bird JL, Wright EE, Feldman JM. Pancreatic islets: a tissue rich in serotonin. Diabetes 1980;29:304-308
11. Schraenen A, Lemaire K, de Faudeur G, et al. Placental lactogens induce serotonin biosynthesis in a subset of mouse beta cells during pregnancy. Diabetologia 2010;53:2589-2599
12. Ding WG, Fujimura M, Tooyama I, Kimura H. Phylogenetic study of serotonin-immunoreactive structures in the pancreas of various vertebrates. Cell Tissue Res 1991;263:237-243
13. Paulmann N, Grohmann M, Voigt JP, et al. Intracellular serotonin modulates insulin secretion from pancreatic beta-cells by protein serotonylation. PLoS Biol 2009;7:e1000229
14. Kim H, Toyofuku Y, Lynn FC, et al. Serotonin regulates pancreatic beta cell mass during pregnancy. Nat Med 2010;16:804-808
15. Lundquist P, Blomquist G, Hartvig P, et al. Validation studies on the 5-hydroxy-L-[beta-11C]-tryptophan/PET method for probing the decarboxylase step in serotonin synthesis. Synapse 2006;59:521-531
16. Orlefors H, Sundin A, Ahlström H, et al. Positron emission tomography with 5-hydroxytryprophan in neuroendocrine tumors. J Clin Oncol 1998;16:2534-2541
17. Orlefors H, Sundin A, Garske U, et al. Whole-body (11) C-5-hydroxytryptophan positron emission tomography as a universal imaging technique for neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and computed tomography. J Clin Endocrinol Metab 2005;90:3392-3400
18. Eriksson O, Selvaraju RK, Johansson L, et al. Quantitative imaging of serotonergic biosynthesis and degradation in the endocrine pancreas. J Nucl Med 2014;55:460-465
19. Eriksson 0, Selvaraju R, Borg B, Asplund V, Estrada S, Antoni G. 5-Fluoro-[ß-11C]-L-tryptophan is a functional analogue of 5-hydroxy- [ß-11C] - L-tryptophan in vitro but not in vivo. Nucl Med Biol 2013;40:567-575
20. Gylfe E, Heilman B, Sehlin J, Taljedal IB. Amino acid conversion into 5-hydroxytryptamine in pancreatic beta-cells. Endocrinology 1973;93:932-937
21. Jaim-Etcheverry G, Zieher LM. Electron microscopic cytochemistry of 5-hydroxytryptamine (5-HT) in the beta cells of guinea pig endocrine pancreas. Endocrinology 1968;83:917-923
22. 11C-hydroxytryptophan uptake and metabolism in endocrine and exocrine pancreas. J Nucl Med 2012; 53:1755-1763
23. Carlsson PO, Olsson R, Källskog O, Bodin B, Andersson A, Jansson L. Glucose-induced islet blood flow increase in rats: Interaction between nervous and metabolic mediators. Am J Physiol Endocrinol Metab 2002;283:E457-E464
24. Orlefors H, Sundin A, Lu L, et al. Carbidopa pretreatment improves image interpretation and visualisation of carcinoid tumours with 11C-5-hydroxytryptophan positron emission tomography. Eur J Nucl Med Mol Imaging 2006;33:60-65
25. Herrero P, Markham J, Bergmann SR. Quantitation of myocardial blood flow with H2 150 and positron emission tomography: Assessment and error analysis of a mathematical approach. J Comput Assist Tomogr 1989;13: 862-873
26. Pisania A, Weir GC, O'Neil JJ, et al. Quantitative analysis of cell composition and purity of human pancreatic islet preparations. Lab Invest 2010; 90:1661-1675
27. Heilman B. Actual distribution of the number and volume of the islets of Langerhans in different size classes in non-diabetic humans of varying ages. Nature 1959;184(Suppl. 19):1498-1499
28. Rahier J, Goebbels RM, Henquin JC. Cellular composition of the human diabetic pancreas. Diabetologia 1983;24:366-371
29. Rahier J, Guiot Y, Goebbels RM, Sempoux C, Henquin JC. Pancreatic betacell mass in European subjects with type 2 diabetes. Diabetes Obes Metab 2008; 10(Suppl. 4):32-42
30. Goda K, Sasaki E, Nagata K, Fukai M, Ohsawa N, Hahafusa T. Pancreatic volume in type 1 and type 2 diabetes mellitus. Acta Diabetol 2001;38:145-149
31. Williams AJ, Thrower SL, Sequeiros IM, et al. Pancreatic volume is reduced in adult patients with recently diagnosed type 1 diabetes. J Clin Endocrinol Metab 2012;97:E2109-E2113
32. Hirshberg B, Qiu M, Cali AM, et al. Pancreatic perfusion of healthy individuals and type 1 diabetic patients as assessed by magnetic resonance perfusion imaging. Diabetologia 2009;52:1561-1565
33. Maffei A, Liu Z, Witkowski P, et al. Identification of tissue-restricted transcripts in human islets. Endocrinology 2004;145:4513-4521
34. Jahan M, Eriksson O, Johnström P, et al. Decreased defluorination using the novel beta-cell imaging agent [18F]FE-DTBZ-d4 in pigs examined by PET. EJNMMI Res 2011;1:33
35. Fagerholm V, Mikkola KK, Ishizu T, et al. Assessment of islet specificity of dihydrotetrabenazine radiotracer binding in rat pancreas and human pancreas. J Nucl Med 2010;51:1439-1446
36. Eriksson O, Jahan M, Johnström P, et al. In vivo and in vitro characterization of [18F]-FE-(+)-DTBZ as a tracer for beta-cell mass. Nucl Med Biol 2010;37:357-363
37. Virostko J, Henske J, Vinet L, et al. Multimodal image coregistration and inducible selective cell ablation to evaluate imaging ligands. Proc Natl Acad Sci U SA 2011;108:20719-20724
38. Lubberink M, Lilja J, Lindsjö L, et al. Low-dose, quantitative images of cerebral glucose metabolism using principal component analysis of dynamic [18F]FDG PET images. Presented at the SNM Annual Meeting, 9-13 June 2012, Miami Beach, FL